Clinical Trial Update: A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322 [Phase 4]

View source ↗

Summary

A Phase 4 double-blind study evaluating coadministration of AD-4833 and SYR-322 in diabetes mellitus; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• AD-4833
• SYR-322

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED